Investigation of Ivs14+1G>A Polymorphism of Dpyd Gene in a Group of Bosnian Patients Treated with 5-Fluorouracil and Capecitabine

Investigation of Ivs14+1G>A Polymorphism of Dpyd Gene in a Group of Bosnian Patients Treated with 5-Fluorouracil and Capecitabine

Adverse drug reactions still pose an important clinical problem. Dihydropyrimidine dehydrogenase (DPD) is an enzyme that regulates 5-FU quantities available for anabolic processes and hence affects its pharmacokinetics, toxicity and efficacy. There are several studies describing a hereditary (pharma...

Full description

Bibliographic Details
Main Authors: Timur Cerić, Nermina Obralić, Lejla Kapur-Pojskić, Draženka Macić, Semir Bešlija, Anes Pašić, Šejla Cerić
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2010-05-01
Series:Bosnian Journal of Basic Medical Sciences
Subjects:
pharmacogenetics
Dihydropyrimidine dehydrogenase
DPYD2A mutation
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/2712

Internet

https://www.bjbms.org/ojs/index.php/bjbms/article/view/2712

Similar Items